₹2,516.30
+₹44.50 (+1.80%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹18,790 Cr
P/E
27.71
ROE
17.88%
ROCE
22.30%
About Caplin Point Laboratories Ltd
Caplin Point Laboratories manufactures wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations.
Founded
1990
CEO
C C Paarthipan
Employees
5,532
HQ
Chennai, India
About Caplin Point Laboratories Ltd
Caplin Point Laboratories manufactures wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations.
Founded:1990
CEO:C C Paarthipan
Employees:5,532
HQ:Chennai, India
Finished Products
1Sales
₹1,349.77Cr2Export Incentives
₹24.77Cr3Service Income
₹2.96CrRaw Materials
1Raw Material Consumed
₹308.77Cr2Purchases of Stock in Trade
₹77.17Cr3Purchase of Traded goods
₹76.77CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,699
52W Low
₹1,500
Volume59.94K
Avg VolumeN/A
Beta0.90
Dividend Yield0.16%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
27.71x
Valuation
P/B Ratio
5.24x
Valuation
EPS
₹89.20
Valuation
Dividend Yield
0.16%
Valuation
ROE
17.88%
Profitability
ROCE
22.30%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacture of pharmaceuticals formRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
A
American Remedies Inc
United States
0.00% stakeC
Concord Laboratories Inc
United States
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
9.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.